Literature DB >> 26268143

Pictorial review. Diagnosis of recurrent prostate cancer and its mimics at multiparametric prostate MRI.

Mark Notley1, Jinxing Yu1, Ann S Fulcher1, Mary Ann Turner1, Charles H Cockrell1, Don Nguyen2.   

Abstract

Biochemical recurrence after treatment for prostate cancer (PCa) is a significant issue. Early diagnosis of local recurrence is important for making prompt treatment decisions and is strongly associated with patient prognosis. Without salvage therapy, the average time from development of local recurrence to distant metastasis is approximately 3 years. Biochemical recurrence does not differentiate local recurrence from systemic disease; there is no reliable way to clinically diagnose local recurrence. Recent advances in multiparametric MRI (mp-MRI) techniques have markedly improved detection of local recurrence following therapy. However, a wide variety of entities can mimic recurrent PCa at mp-MRI. Therefore, the purpose of this pictorial review is to discuss the MRI findings of locally recurrent PCa and its mimics, emphasizing the key MRI features that help to differentiate local recurrence from its mimics.

Entities:  

Mesh:

Year:  2015        PMID: 26268143      PMCID: PMC4730977          DOI: 10.1259/bjr.20150362

Source DB:  PubMed          Journal:  Br J Radiol        ISSN: 0007-1285            Impact factor:   3.039


  12 in total

1.  Retained seminal vesicles after radical prostatectomy: frequency, MRI characteristics, and clinical relevance.

Authors:  Tamar Sella; Lawrence H Schwartz; Hedvig Hricak
Journal:  AJR Am J Roentgenol       Date:  2006-02       Impact factor: 3.959

2.  MR imaging evaluation with a transrectal surface coil of local recurrence of prostatic cancer in men who have undergone radical prostatectomy.

Authors:  J M Silverman; T L Krebs
Journal:  AJR Am J Roentgenol       Date:  1997-02       Impact factor: 3.959

Review 3.  Treatment options for localized prostate cancer.

Authors:  Mira Keyes; Juanita Crook; Gerard Morton; Eric Vigneault; Nawaid Usmani; W James Morris
Journal:  Can Fam Physician       Date:  2013-12       Impact factor: 3.275

4.  Locally recurrent prostate cancer after external beam radiation therapy: diagnostic performance of 1.5-T endorectal MR imaging and MR spectroscopic imaging for detection.

Authors:  Antonio C Westphalen; Fergus V Coakley; Mack Roach; Charles E McCulloch; John Kurhanewicz
Journal:  Radiology       Date:  2010-06-15       Impact factor: 11.105

5.  Long-term oncologic results of salvage radical prostatectomy for locally recurrent prostate cancer after radiotherapy.

Authors:  Fernando J Bianco; Peter T Scardino; Andrew J Stephenson; Christopher J Diblasio; Paul A Fearn; James A Eastham
Journal:  Int J Radiat Oncol Biol Phys       Date:  2005-06-01       Impact factor: 7.038

6.  Suspected local recurrence after radical prostatectomy: endorectal coil MR imaging.

Authors:  Tamar Sella; Lawrence H Schwartz; Peter W Swindle; Chinyere N Onyebuchi; Peter T Scardino; Howard I Scher; Hedvig Hricak
Journal:  Radiology       Date:  2004-04-02       Impact factor: 11.105

7.  MR imaging of prostate after treatment with high-intensity focused ultrasound.

Authors:  Alexander P S Kirkham; Mark Emberton; Ivan M Hoh; Rowland O Illing; A Alex Freeman; Clare Allen
Journal:  Radiology       Date:  2008-01-25       Impact factor: 11.105

8.  Focal salvage guided by T2-weighted and dynamic contrast-enhanced magnetic resonance imaging for prostate cancer recurrences.

Authors:  Maaike R Moman; Cornelis A T van den Berg; Arto E Boeken Kruger; Jan J Battermann; Marinus A Moerland; Uulke A van der Heide; Marco van Vulpen
Journal:  Int J Radiat Oncol Biol Phys       Date:  2009-10-03       Impact factor: 7.038

9.  Diffusion-weighted MRI for locally recurrent prostate cancer after external beam radiotherapy.

Authors:  Veronica A Morgan; Sophie F Riches; Sharon Giles; David Dearnaley; Nandita M deSouza
Journal:  AJR Am J Roentgenol       Date:  2012-03       Impact factor: 3.959

Review 10.  Focal therapy for prostate cancer: The current status.

Authors:  Susan Marshall; Samir Taneja
Journal:  Prostate Int       Date:  2015-03-23
View more
  7 in total

Review 1.  Prostate MR Imaging for Posttreatment Evaluation and Recurrence.

Authors:  Sonia Gaur; Baris Turkbey
Journal:  Radiol Clin North Am       Date:  2017-11-27       Impact factor: 2.303

Review 2.  Multiparametric Magnetic Resonance Imaging of Recurrent Prostate Cancer.

Authors:  Francesca V Mertan; Matthew D Greer; Sam Borofsky; Ismail M Kabakus; Maria J Merino; Bradford J Wood; Peter A Pinto; Peter L Choyke; Baris Turkbey
Journal:  Top Magn Reson Imaging       Date:  2016-06

3.  Imaging in Prostate Cancer: Magnetic Resonance Imaging and Beyond.

Authors:  Daniel R Ludwig; Tyler J Fraum; Kathryn J Fowler; Joseph E Ippolito
Journal:  Mo Med       Date:  2018 Mar-Apr

Review 4.  Contrast-Enhanced Transrectal Ultrasound in Focal Therapy for Prostate Cancer.

Authors:  Akbar N Ashrafi; Nima Nassiri; Inderbir S Gill; Mittul Gulati; Daniel Park; Andre L de Castro Abreu
Journal:  Curr Urol Rep       Date:  2018-08-28       Impact factor: 2.862

5.  Salvage high-dose-rate brachytherapy for histologically confirmed macroscopic local relapsed prostate cancer after radical prostatectomy.

Authors:  David Buchser; Alfonso Gomez-Iturriaga; J Ignacio Rodriguez Melcon; Francisco Casquero; Roberto Llarena; Jon Cacicedo; Pedro Bilbao
Journal:  J Contemp Brachytherapy       Date:  2016-12-06

6.  A case of CRPC with multiple bladder invasions treated with EBRT followed by HDR-BT boost.

Authors:  Yoshiaki Takagawa; Jun Itami
Journal:  BJR Case Rep       Date:  2022-03-09

Review 7.  Prostate minimally invasive procedures: complications and normal vs. abnormal findings on multiparametric magnetic resonance imaging (mpMRI).

Authors:  Thanh-Lan Bui; Justin Glavis-Bloom; Chantal Chahine; Raj Mehta; Taylor Wolfe; Param Bhatter; Mark Rupasinghe; Joseph Carbone; Masoom A Haider; Francesco Giganti; Simone Giona; Aytekin Oto; Grace Lee; Roozbeh Houshyar
Journal:  Abdom Radiol (NY)       Date:  2021-05-11
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.